title: Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model.
abstract: OBJECTIVE
  The purpose of this study was to provide direct evidences that rotor ablation suppresses atrial fibrillation (AF) inducibility.
  
  
  BACKGROUND
  Micro-re-entrant wavefronts have been suggested to serve as sources of rapid activations during AF. Whether AF inducibility is suppressed by elimination of rotors remains unknown.
  
  
  METHODS
  We used optical mapping to study Langendorff-perfused left pulmonary vein (PV)-left atrium (LA) preparations from 13 dogs with pacing-induced heart failure. Atrial arrhythmias were induced by pacing and mapped during acetylcholine infusion (1 μmol/l). Rotors were identified from optical recordings. Epicardial ablation was performed targeting the rotor anchoring sites in preparations with sustained (>10 min) or incessant spontaneous AF. Non-rotor ablation was performed in 4 preparations. Repeated pacing was performed to test the AF inducibility after ablation.
  
  
  RESULTS
  Sustained AF (n = 12) and incessant spontaneous AF (n = 1) were induced after acetylcholine infusion. Pulmonary vein focal discharge was found in 9 preparations (9.2 ± 4.2 beats/s), and rotor anchoring was found at the left superior PV-LA junction in 13 preparations (9.1 ± 4.6 beats/s) and at the ligament of Marshall-PV-LA junction in 1 preparation. Epicardial rotor ablation successfully inhibited the inducibility of sustained AF in 12 of 13 preparations (p < 0.01), including 4 with the maximal dominant frequency sites located on the PV-LA junctional rotor zones (direct elimination of mother rotors). The longest AF duration was shortened significantly by rotor ablation (Wilcoxon Z = 3.60, p = 0.002, n = 13), but not by non-rotor ablation (Wilcoxon Z = 1.00, p = 0.317, n = 4).
  
  
  CONCLUSIONS
  Epicardial ablation of the rotor anchoring sites suppresses AF inducibility. The arrhythmogenicity at the maximal dominant frequency sites is directly/indirectly suppressed by the rotor ablation.
authors: Second Section of Cardiology, Department of Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan. 2867@adm.cgmh.org.tw
authors: Chung-Chuan
authors: CC
authors: Chou
authors: Po-Cheng
authors: PC
authors: Chang
authors: Ming-Shien
authors: MS
authors: Wen
authors: Hui-Ling
authors: HL
authors: Lee
authors: Tse-Ching
authors: TC
authors: Chen
authors: San-Jou
authors: SJ
authors: Yeh
authors: Delon
authors: D
authors: Wu
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D001281:Atrial Fibrillation / Q000473:pathology*; D017115:Catheter Ablation; D002404:Catheterization; D004195:Disease Models, Animal; D004285:Dogs; D006325:Heart Atria / Q000473:pathology*; D006333:Heart Failure / Q000473:pathology*; D008564:Membrane Potentials; D010477:Perfusion; D010496:Pericardium / Q000473:pathology*; D011667:Pulmonary Veins / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000109:Acetylcholine